Identification of common genetic risk variants for autism spectrum disorder
Year: 2019
Type: article
Study design: Observational Study
Abstract: Autism spectrum disorder (ASD) is a highly heritable and heterogeneous group of neurodevelopmental phenotypes diagnosed in more than 1% of children. Common genetic variants contribute substantially to ASD susceptibility, but to date no individual variants have been robustly associated with ASD. With a marked sample-size increase from a unique Danish population resource, we report a genome-wide association meta-analysis of 18,381 individuals with ASD and 27,969 controls that identified five genome-wide-significant loci. Leveraging GWAS results from three phenotypes with significantly overlapping genetic architectures (schizophrenia, major depression, and educational attainment), we identified seven additional loci shared with other traits at equally strict significance levels. Dissecting the polygenic architecture, we found both quantitative and qualitative polygenic heterogeneity across ASD subtypes. These results highlight biological insights, particularly relating to neuronal function and corticogenesis, and establish that GWAS performed at scale will be much more productive in the near term in ASD. A genome-wide-association meta-analysis of 18,381 austim spectrum disorder (ASD) cases and 27,969 controls identifies five risk loci. The authors find quantitative and qualitative polygenic heterogeneity across ASD subtypes.
Source: Nature Genetics
Authors: Jakob Grove, BUPGEN, Stephan Ripke, Thomas D. Als, Manuel Mattheisen, Raymond K. Walters, Hyejung Won, Jonatan Pallesen, Esben Agerbo, Ole A. Andreassen, Richard Anney, Swapnil Awashti, Rich Belliveau, Francesco Bettella, Joseph D. Buxbaum, Jonas Bybjerg-Grauholm, Marie Bækvad-Hansen, Felecia Cerrato, Kimberly Chambert, Jane H. Christensen, Claire Churchhouse, Karin Dellenvall, Ditte Demontis, Silvia De Rubeis, Bernie Devlin, Srdjan Djurovic, Ashley L. Dumont, Jacqueline I. Goldstein, Christine S. Hansen, Mads Engel Hauberg, Mads V. Hollegaard, Sigrun Hope, Daniel P. Howrigan, Hailiang Huang, Christina M. Hultman, Lambertus Klei, Julian Maller, Joanna Martin, Alicia R. Martin, Jennifer L. Moran, Mette Nyegaard, Terje Nærland, Duncan S. Palmer, Aarno Palotie, Carsten Bøcker Pedersen, Marianne Giørtz Pedersen, Timothy dPoterba, Jesper Buchhave Poulsen, Beate St Pourcain, Per Qvist, Karola Rehnström, Abraham Reichenberg, Jennifer Reichert, Elise B. Robinson, Kathryn Roeder, Panos Roussos, Evald Saemundsen, Sven Sandin, F. Kyle Satterstrom, George Davey Smith, Hreinn Stefansson, Stacy Steinberg, Christine R. Stevens, Patrick F. Sullivan, Patrick Turley, G. Bragi Walters, Xinyi Xu, Kari Stefansson, Daniel H. Geschwind, Merete Nordentoft, David M. Hougaard, Thomas Werge, Ole Mors, Preben Bo Mortensen, Benjamin M. Neale, Mark J. Daly, Anders D. Børglum
Institutions: Aarhus University, Lundbeck Foundation, Harvard University, Massachusetts General Hospital, Broad Institute, Stanley Center for Psychiatric Research, Charité – Universitätsmedizin Berlin, University of Würzburg, Karolinska Institutet, University of North Carolina at Chapel Hill, University of Oslo, Oslo University Hospital, Cardiff University, Icahn School of Medicine at Mount Sinai, Statens Serum Institut, University of Pittsburgh, Mental Health Services, Vertex Pharmaceuticals (United Kingdom), Genomics (United Kingdom), University of Helsinki, Institute for Molecular Medicine Finland, Max Planck Institute for Psycholinguistics, Radboud University Nijmegen, University of Bristol, MRC Integrative Epidemiology Unit, Donders Institute for Brain, Cognition and Behaviour, Wellcome Sanger Institute, Carnegie Mellon University, James J. Peters VA Medical Center, Mental Illness Research, Education and Clinical Centers, deCODE Genetics (Iceland), University of Iceland, University of California, Los Angeles, University of Copenhagen, Capital Region of Denmark, Aarhus University Hospital
Language: English
Subfield: Cognitive Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Funders: Simons Foundation, Aarhus Universitet, Wellcome Trust, Simons Foundation Autism Research Initiative, Lundbeckfonden, Novo Nordisk, Norges Forskningsråd, Novo Nordisk Fonden, H. Lundbeck A/S, National Institutes of Health, Gillings School of Public Health, Medical Research Council, Helse Sør-Øst RHF, National Institute of Mental Health, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Genetics and gene regulation in the inflammatory bowel diseases, 5/7 Psychiatric Genomics Consortium: Finding actionable variation, Centre for Cognitive Ageing & Cognitive Epidemiology, G1489408117, 1/4 - The Autism Sequencing Consortium: Autism Gene Discovery in >50,000 Exomes, G1899771904, G19851776, G214445032, Population-Based Autism Genetics and Environment Study, Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC Supercomputer, G3246699782, G3433676821, G3987400284, G4249767000, G4261582792, 3/7 Psychiatric Genomics Consortium: Finding actionable variation, MRC Centre for Neuropsychiatric Genetics and Genomics, Quantitative Traits in Health and Disease, Data commons for 'omic, microscopy and analysis core facilities, Mendelian randomization to hypothesis-free causal inference, Connecting gene regulatory mechanisms in human brain to psychiatric illness, A genetic study examining sex differences in the prevalence of ADHD and other neurodevelopmental disorders., Population-Based Autism Genetics & Environment Study, Discovering Biology for Neuropsychiatric Diseases Through Omics Studies on Comorbidities, 2/4-Psychiatric GWAS Consortium: Genomic Follow-Up Next-Gen Sequencing & Genotypi
OpenAlex ID: W2914482125
